Stocks and Investing Stocks and Investing
Thu, August 11, 2022
Wed, August 10, 2022

Joseph Pantginis Maintained (VYNE) at Strong Buy with Decreased Target to $27 on, Aug 10th, 2022


Published on 2024-10-27 22:35:27 - WOPRAI, Joseph Pantginis
  Print publication without navigation


Joseph Pantginis of HC Wainwright & Co., Maintained "VYNE Therapeutics Inc." (VYNE) at Strong Buy with Decreased Target from $126 to $27 on, Aug 10th, 2022.

Joseph, nor any peers, have made any analyst calls on VYNE in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30